4//SEC Filing
Crombez Eric 4
Accession 0000950170-24-046055
CIK 0001515673other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:35 PM ET
Size
4.8 KB
Accession
0000950170-24-046055
Insider Transaction Report
Form 4
Crombez Eric
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2024-04-18$44.10/sh−142$6,262→ 48,785 total
Footnotes (2)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001653052
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:35 PM ET
- Size
- 4.8 KB